ArticleVeterinary research communications2026
Effect of recombinant human follicle-stimulating hormone or equine chorionic gonadotropin on the ovarian response in guinea pig.
Article in Veterinary research communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study evaluated the effect of recombinant human FSH/LH (r-hFSH/r-hLH) or equine chorionic gonadotropin (eCG) within two synchronization protocols on ovarian response in guinea pig. A total of 87 nulliparous females were used. Two synchronization protocols were performed (S1, S2). S1 involved oral administration of 0.4 mg/day altrenogest for 10 days, 0.0657 mg cloprostenol sodium intramuscularly on day 7, and 0.0013 mg buserelin acetate intramuscularly on day 10. S2 involved intramuscular injections of 0.0013 mg buserelin acetate on days 0 and 10, and 0.0657 mg cloprostenol sodium on day 7. Superovulation was induced using either r-hFSH/r-hLH (0.5 µg every 12 h from day 7 to 9 of the protocol) or a single dose of eCG (20 IU) on day 7. The experimental groups were: S1 - eCG, S1 - r-hFSH/r-hLH, S2 - eCG (n = 15 each), and S2 - r-hFSH/r -hLH (n = 12), plus control groups (S1 and S2, n = 15 each). Data were analyzed using a general linear model including synchronization protocol, superovulation treatment, and their interaction as fixed effects, and initial body weight as a covariate. Statistical analysis was conducted using RStudio v.4.4.2. Results showed that the ovulation rate was similar across almost all groups. However, the S2-r-hFSH/r-hLH group showed the highest number of corpora lutea (9.49 ± 0.90). The number of normal embryos recovered was similar between the S2-eCG and S2-r-hFSH/r-hLH groups. These findings suggest that applying the S2-eCG or S2-r-hFSH/r-hLH protocol in female guinea pigs increases the number of embryos recovered.
Indexed as
Identifiers
42213185What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.